Literature DB >> 1898588

The spindle is required for the process of sister chromatid separation in Drosophila neuroblasts.

C Gonzalez1, J Casal Jimenez, P Ripoll, C E Sunkel.   

Abstract

We have studied two aspects of the process of sister chromatid separation in the Drosophila melanogaster neuroblasts. First, we analyzed the requirement of a functional spindle for sister chromatid separation to take place using microtubule depolymerizing drugs such as colchicine or a reversible analogue (MTC). Incubation of this tissue in colchicine causes the cells to block irreversibly at metaphase and no significant levels of sister chromatid separation were observed even after long periods of incubation. Exposure of neuroblasts to MTC also causes cells to block at metaphase, but after reversion most of the cells enter anaphase and are thus able to complete sister chromatid separation. These results imply that a functional spindle is required for sister chromatid separation. Second, we studied the role of heterochromatin during chromatid pairing and subsequent separation in chromosomes which carry either one or two extra pieces of heterochromatin. The results indicate that sister chromatids establish strong pairing along the translocated heterochromatin. During the early stages of anaphase, these chromosomes separate first the centromeric region and later the regions bearing extra heterochromatin. These results indicate that constitutive heterochromatin plays an important role for sister chromatid pairing and might be involved in the process of separation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1898588     DOI: 10.1016/0014-4827(91)90150-s

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  15 in total

1.  Somatic instability of a Drosophila chromosome.

Authors:  D R Wines; S Henikoff
Journal:  Genetics       Date:  1992-07       Impact factor: 4.562

Review 2.  Cohesin regulation: fashionable ways to wear a ring.

Authors:  Ana Losada
Journal:  Chromosoma       Date:  2007-03-01       Impact factor: 4.316

3.  Zwilch, a new component of the ZW10/ROD complex required for kinetochore functions.

Authors:  Byron C Williams; ZeXiao Li; Songtao Liu; Erika V Williams; Garmay Leung; Tim J Yen; Michael L Goldberg
Journal:  Mol Biol Cell       Date:  2003-04       Impact factor: 4.138

4.  Genetic and molecular analysis of wings apart-like (wapl), a gene controlling heterochromatin organization in Drosophila melanogaster.

Authors:  F Vernì; R Gandhi; M L Goldberg; M Gatti
Journal:  Genetics       Date:  2000-04       Impact factor: 4.562

5.  Double or nothing: a Drosophila mutation affecting meiotic chromosome segregation in both females and males.

Authors:  D P Moore; W Y Miyazaki; J E Tomkiel; T L Orr-Weaver
Journal:  Genetics       Date:  1994-03       Impact factor: 4.562

6.  Pattern of chromosomal localization of the Hoppel transposable element family in the Drosophila melanogaster subgroup.

Authors:  P A Coelho; J Queiroz-Machado; D Hartl; C E Sunkel
Journal:  Chromosome Res       Date:  1998-08       Impact factor: 5.239

7.  Transposable elements map in a conserved pattern of distribution extending from beta-heterochromatin to centromeres in Drosophila melanogaster.

Authors:  M Carmena; C González
Journal:  Chromosoma       Date:  1995-07       Impact factor: 4.316

8.  Heterochromatin protein 1 (HP1) proteins do not drive pericentromeric cohesin enrichment in human cells.

Authors:  Angel Serrano; Miriam Rodríguez-Corsino; Ana Losada
Journal:  PLoS One       Date:  2009-04-08       Impact factor: 3.240

9.  Strategies for outcrossing and genetic manipulation of Drosophila compound autosome stocks.

Authors:  T Martins; S Kotadia; N Malmanche; C E Sunkel; W Sullivan
Journal:  G3 (Bethesda)       Date:  2013-01-01       Impact factor: 3.154

10.  Exit from mitosis is regulated by Drosophila fizzy and the sequential destruction of cyclins A, B and B3.

Authors:  S Sigrist; H Jacobs; R Stratmann; C F Lehner
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.